Tag Archives: Alba Therapeutics

Innovate Biopharmaceuticals Completes License For Late-Stage Celiac Disease Asset From Alba Therapeutics

298549_InnovateBiopharmalogo_300x87[1]

-Alba Therapeutics has been working on a therapy for celiac disease the past 8 years. Alba’s therapy, Larazotide Acetate, is the first to reach phase 3 clinical trials, where it will be given to large groups of people. When Alba first contacted us about helping to promote their phase 2 clinical trial, we investigated the therapy’s mechanism and were glad ...

Read More »

Medical Research Study to Test a Potential Celiac Disease Therapy Is Underway and Signing up Participants

There is no cure for celiac disease. But, there may soon be a new therapy to go along with a gluten-free diet. A Phase II medical research study to test a potential therapy for people with celiac disease is underway and signing up participants at CeliacTrial.com. The investigational drug, Larazotide Acetate, was developed by Alba Therapeutics. It passed Phase I ...

Read More »